Laboratory Corporation of America Holdings (LH) Balance Sheet
A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.
Labcorp Holdings Inc. provides laboratory services. It operates in Diagnostics Laboratories and Biopharma Laboratory Services segments.
Total Assets Chart for Laboratory Corporation of America Holdings
Laboratory Corporation of America Holdings (LH) total assets for FY2025 were USD 18.4B, a 0.1% change from FY2024. Laboratory Corporation of America Holdings's total assets grew from USD 368.2M in 1989 to USD 18.4B in 2025 (4895.3% over 36 years). Total assets compound annual growth rate: 5-year CAGR of -1.7%, 10-year CAGR of 2.6%, 20-year CAGR of 8.1%.
Total Assets (US Dollars)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- $25.40B
- Implied Share Price
- $313.96
- Enterprise Value
- $31.89B
- Revenue (TTM)
- $14.35B
- EBITDA
- $2.32B
- Profit Margin
- 6.99%
- Trailing P/E
- 25.97
- Forward P/E
- 17.21
- Price/Book (MRQ)
- 2.94
- Price/Sales (TTM)
- 1.79
- EV/EBITDA
- 14.78
- EV/Revenue
- 2.22
- Dividend Yield
- 0.92%
- Book Value
- $106.39
- Free Cash Flow (FY2025)
- $1.21B
- Free Cash Flow Yield
- 4.75%
Snapshot as of 6th August 2026 — not point-in-time controlled, may lag the live market by a few days.